FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4378373113> ?p ?o ?g. }

• W4378373113 endingPage "e47869" @default.
• W4378373113 startingPage "e47869" @default.
• W4378373113 abstract "The management of chronic pelvic pain in women with endometriosis is complex and includes the long-term use of opioids. Patients not fully responsive to drugs or ineligible for surgical treatments need efficient alternatives to improve their quality of life and avoid long-term sequelae.This randomized controlled trial aimed to assess the effects of repeated at-home administrations of a 20-minute virtual reality (VR) solution (Endocare) compared with a sham condition on pain in women experiencing pelvic pain due to endometriosis.Patients were instructed to use the VR headsets twice daily for at least 2 days and for up to 5 days starting on their first day of painful periods. Pain perception was measured using a numerical scale (0-10) before and 60, 120, and 180 minutes after each treatment administration. General pain, stress, fatigue, medication intake, and quality of life were reported daily by patients.A total of 102 patients with endometriosis were included in the final analysis (Endocare group: n=51, 50%; sham group: n=51, 50%). The mean age was 32.88 years (SD 6.96) and the mean pain intensity before treatment was 6.53 (SD 1.74) and 6.22 (SD 1.69) for the Endocare group and the sham control group, respectively (P=.48). Pain intensity decreased in both groups from day 1 to day 5 along with a decrease in medication use. Maximum pain intensity reduction of 51.58% (SD 35.33) occurred at day 2, 120 minutes after treatment for the Endocare group and of 27.37% (SD 27.23) at day 3, 180 minutes after treatment for the control group. Endocare was significantly superior to the sham on day 1 (120 minutes, P=.04; 180 minutes, P=.001), day 2 (0 minutes, P=.02; 60, 120, and 180 minutes, all P<.001), and day 3 (60 minutes, P=.01; 120 minutes, P=.005; 180 minutes, P=.001). Similarly, the mean perceived pain relief was significantly higher with Endocare on day 1 (120 and 180 minutes P=.004 and P=.001, respectively) and day 2 (60, 120, and 180 minutes P=.003, P=.004, and P=.007, respectively) compared to the control. No adverse event was reported.This study confirmed the effectiveness and safety of self-repeated administrations of a VR immersive treatment used at home while reducing overall pain medication intake in women diagnosed with endometriosis experiencing moderate-to-severe pelvic pain.ClinicalTrials.gov NCT05172492; https://clinicaltrials.gov/ct2/show/NCT05172492." @default.
• W4378373113 created "2023-05-27" @default.
• W4378373113 creator A5028040692 @default.
• W4378373113 creator A5029478749 @default.
• W4378373113 creator A5034601880 @default.
• W4378373113 creator A5039729384 @default.
• W4378373113 creator A5054459923 @default.
• W4378373113 creator A5075531083 @default.
• W4378373113 creator A5077151564 @default.
• W4378373113 creator A5085506231 @default.
• W4378373113 creator A5086664372 @default.
• W4378373113 date "2023-06-28" @default.
• W4378373113 modified "2023-10-14" @default.
• W4378373113 title "Pain Reduction With an Immersive Digital Therapeutic in Women Living With Endometriosis-Related Pelvic Pain: At-Home Self-Administered Randomized Controlled Trial" @default.
• W4378373113 cites W1513717411 @default.
• W4378373113 cites W2003387489 @default.
• W4378373113 cites W2008135715 @default.
• W4378373113 cites W2012650501 @default.
• W4378373113 cites W2015901402 @default.
• W4378373113 cites W2020712684 @default.
• W4378373113 cites W2041484523 @default.
• W4378373113 cites W2049967511 @default.
• W4378373113 cites W2085922363 @default.
• W4378373113 cites W2086214501 @default.
• W4378373113 cites W2098503209 @default.
• W4378373113 cites W2099442165 @default.
• W4378373113 cites W2152955646 @default.
• W4378373113 cites W2160662805 @default.
• W4378373113 cites W2167099079 @default.
• W4378373113 cites W2329142543 @default.
• W4378373113 cites W2404431760 @default.
• W4378373113 cites W2417879924 @default.
• W4378373113 cites W2520837860 @default.
• W4378373113 cites W2771659883 @default.
• W4378373113 cites W2789651299 @default.
• W4378373113 cites W2790065268 @default.
• W4378373113 cites W2791733532 @default.
• W4378373113 cites W2808255070 @default.
• W4378373113 cites W2883658446 @default.
• W4378373113 cites W2913620241 @default.
• W4378373113 cites W2917772170 @default.
• W4378373113 cites W2941662568 @default.
• W4378373113 cites W2947250242 @default.
• W4378373113 cites W2955599831 @default.
• W4378373113 cites W2961940022 @default.
• W4378373113 cites W2967545880 @default.
• W4378373113 cites W3007810161 @default.
• W4378373113 cites W3035750743 @default.
• W4378373113 cites W3069151061 @default.
• W4378373113 cites W3093822441 @default.
• W4378373113 cites W3119643745 @default.
• W4378373113 cites W3134885188 @default.
• W4378373113 cites W3154139097 @default.
• W4378373113 cites W3165294846 @default.
• W4378373113 cites W3175000297 @default.
• W4378373113 cites W3193727278 @default.
• W4378373113 cites W4200019418 @default.
• W4378373113 cites W4205836558 @default.
• W4378373113 cites W4211092896 @default.
• W4378373113 cites W4229025833 @default.
• W4378373113 cites W4285365916 @default.
• W4378373113 cites W4291012209 @default.
• W4378373113 cites W4294397905 @default.
• W4378373113 cites W4309949304 @default.
• W4378373113 cites W4320076207 @default.
• W4378373113 doi "https://doi.org/10.2196/47869" @default.
• W4378373113 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37260160" @default.
• W4378373113 hasPublicationYear "2023" @default.
• W4378373113 type Work @default.
• W4378373113 citedByCount "0" @default.
• W4378373113 crossrefType "journal-article" @default.
• W4378373113 hasAuthorship W4378373113A5028040692 @default.
• W4378373113 hasAuthorship W4378373113A5029478749 @default.
• W4378373113 hasAuthorship W4378373113A5034601880 @default.
• W4378373113 hasAuthorship W4378373113A5039729384 @default.
• W4378373113 hasAuthorship W4378373113A5054459923 @default.
• W4378373113 hasAuthorship W4378373113A5075531083 @default.
• W4378373113 hasAuthorship W4378373113A5077151564 @default.
• W4378373113 hasAuthorship W4378373113A5085506231 @default.
• W4378373113 hasAuthorship W4378373113A5086664372 @default.
• W4378373113 hasBestOaLocation W43783731131 @default.
• W4378373113 hasConcept C126322002 @default.
• W4378373113 hasConcept C141071460 @default.
• W4378373113 hasConcept C14184104 @default.
• W4378373113 hasConcept C159110408 @default.
• W4378373113 hasConcept C168563851 @default.
• W4378373113 hasConcept C1862650 @default.
• W4378373113 hasConcept C2779522080 @default.
• W4378373113 hasConcept C2779951463 @default.
• W4378373113 hasConcept C2780136519 @default.
• W4378373113 hasConcept C42219234 @default.
• W4378373113 hasConcept C71924100 @default.
• W4378373113 hasConceptScore W4378373113C126322002 @default.
• W4378373113 hasConceptScore W4378373113C141071460 @default.
• W4378373113 hasConceptScore W4378373113C14184104 @default.
• W4378373113 hasConceptScore W4378373113C159110408 @default.
• W4378373113 hasConceptScore W4378373113C168563851 @default.
• W4378373113 hasConceptScore W4378373113C1862650 @default.

• next